ApoAI is one of the main HDL components and has anti-inflammatory, antioxidant, anti-platelet aggregation, antirejection, antiviral, and anti-angiogenic activities and is beneficial in obesity-related treatment (Zhang, and Zhang, 2017). This evidence concerns the gene APOA1 and obesity due to melanocortin 4 receptor deficiency.